Publications in collaboration with researchers from Hospital Vall d'Hebron (23)

2022

  1. Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up

    Journal of Parkinson's Disease, Vol. 12, Núm. 3, pp. 935-955

  2. Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group

    Journal of Parkinson's Disease, Vol. 12, Núm. 1, pp. 315-331

2021

  1. Morphological Description of Frontal EEG Interictal and Ictal Discharges in an Adult Cohort of 175 Patients

    Journal of Clinical Medicine, Vol. 10, Núm. 6, pp. 1219

  2. Epigenome-wide association study of COVID-19 severity with respiratory failure

    EBioMedicine, Vol. 66

2020

  1. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

    European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270

  2. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    Cell Reports Medicine, Vol. 1, Núm. 8

  3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  4. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia

  5. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

2019

  1. Management of adult patients with primary immune thrombocytopenia (itp) in clinical practice: A consensus approach of the Spanish itp expert group

    Advances in Hematology, Vol. 2019

  2. Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

    Scientific Reports, Vol. 9, Núm. 1

  3. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

    European Journal of Neurology, Vol. 26, Núm. 11, pp. 1399-1407

2017

  1. Use of eltrombopag for secondary immune thrombocytopenia in clinical practice

    British Journal of Haematology, Vol. 178, Núm. 6, pp. 959-970

  2. Metabolic biomarkers in community obese children: effect of obstructive sleep apnea and its treatment

    Sleep Medicine, Vol. 37, pp. 1-9

  3. Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

    International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516

  4. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

    Hematology, Vol. 22, Núm. 8, pp. 484-492

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

2015

  1. Treatment outcomes of obstructive sleep apnoea in obese community-dwelling children: The NANOS study

    European Respiratory Journal, Vol. 46, Núm. 3, pp. 717-727

2014

  1. Inflammatory markers and obstructive sleep apnea in obese children: The NANOS study

    Mediators of Inflammation, Vol. 2014

  2. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

    Neurobiology of Aging, Vol. 35, Núm. 2, pp. 444.e1-444.e4